• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有腋窝转移的高级别三阴性乳腺癌的自发病理性完全消退。

Spontaneous pathological complete regression of high-grade triple-negative breast cancer with axillary metastasis.

作者信息

Cserni Gábor, Serfozo Orsolya, Ambrózay Éva, Markó László, Krenács László

机构信息

Institute of Pathology, University of Szeged, Szeged, Hungary.

Breast Imaging Unit, Mamma Rt, Kecskemét, Hungary.

出版信息

Pol J Pathol. 2019;70(2):139-143. doi: 10.5114/pjp.2019.87105.

DOI:10.5114/pjp.2019.87105
PMID:31556565
Abstract

We report on a breast carcinoma with medullary features diagnosed by core needle biopsy in a 72-year-old woman. Both the primary tumour and its fine needle aspiration-proven, rapidly growing axillary metastasis regressed completely in less than 2 months, by the time surgery was performed. The biopsy of the primary tumour demonstrated a dense stromal infiltrate of CD8+/granzyme B+ activated cytotoxic T-cells suggestive of a robust antitumour immune response. Paradoxically, both tumour cells and tumour infiltrating immune cells demonstrated a diffuse PD-L1 expression, revealing that antitumour immune response has the ability to spontaneously overcome inhibitory mechanisms induced by cancerous growth.

摘要

我们报告了一例经粗针活检诊断为具有髓样特征的乳腺癌的72岁女性患者。在进行手术时,原发肿瘤及其经细针穿刺证实的快速生长的腋窝转移灶在不到2个月的时间内完全消退。原发肿瘤活检显示CD8+/颗粒酶B+活化细胞毒性T细胞的致密基质浸润,提示强大的抗肿瘤免疫反应。矛盾的是,肿瘤细胞和肿瘤浸润免疫细胞均表现出弥漫性PD-L1表达,表明抗肿瘤免疫反应有能力自发克服癌性生长诱导的抑制机制。

相似文献

1
Spontaneous pathological complete regression of high-grade triple-negative breast cancer with axillary metastasis.伴有腋窝转移的高级别三阴性乳腺癌的自发病理性完全消退。
Pol J Pathol. 2019;70(2):139-143. doi: 10.5114/pjp.2019.87105.
2
Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer.三阴性乳腺癌原发肿瘤与配对淋巴结转移灶中 PD-L1 表达的异质性。
BMC Cancer. 2018 Jan 2;18(1):4. doi: 10.1186/s12885-017-3916-y.
3
Syntenin1/MDA-9 (SDCBP) induces immune evasion in triple-negative breast cancer by upregulating PD-L1.Syntenin1/MDA-9 (SDCBP) 通过上调 PD-L1 在三阴性乳腺癌中诱导免疫逃逸。
Breast Cancer Res Treat. 2018 Sep;171(2):345-357. doi: 10.1007/s10549-018-4833-8. Epub 2018 May 29.
4
The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC).免疫检查点抑制剂的治疗候选物由三阴性乳腺癌(TNBC)中肿瘤浸润淋巴细胞(TILs)和程序性死亡配体 1(PD-L1)表达的状态所阐明。
Breast Cancer. 2018 Jan;25(1):34-42. doi: 10.1007/s12282-017-0781-0. Epub 2017 May 9.
5
[Expression of PD-1/PD-L1 in triple-negative breast carcinoma and its significance].[程序性死亡受体1/程序性死亡受体配体1在三阴性乳腺癌中的表达及其意义]
Zhonghua Bing Li Xue Za Zhi. 2017 Jan 8;46(1):20-24. doi: 10.3760/cma.j.issn.0529-5807.2017.01.005.
6
The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome.在炎性乳腺癌中,同时存在 CD20+B 细胞和 PD-L1+肿瘤浸润淋巴细胞与患者预后改善相关。
Breast Cancer Res Treat. 2018 Sep;171(2):273-282. doi: 10.1007/s10549-018-4834-7. Epub 2018 Jun 1.
7
[PD-L1 status in breast cancer].[乳腺癌中的程序性死亡配体1(PD-L1)状态]
Arkh Patol. 2019;81(2):3-9. doi: 10.17116/patol2019810213.
8
Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.靶向磷脂酰丝氨酸的抗体通过增强免疫激活和下调小鼠三阴性乳腺癌中由T细胞检查点抑制诱导的促癌因子,增强抗PD-1疗法的抗肿瘤活性。
Breast Cancer Res. 2016 May 11;18(1):50. doi: 10.1186/s13058-016-0708-2.
9
[Correlation analysis of PD-L1 expression and prognosis in triple-negative breast cancers].三阴性乳腺癌中PD-L1表达与预后的相关性分析
Zhonghua Bing Li Xue Za Zhi. 2017 Dec 8;46(12):822-826. doi: 10.3760/cma.j.issn.0529-5807.2017.12.002.
10
Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations.程序性死亡配体 1 检测在非小细胞肺癌细胞学细胞块和抽吸涂片制备中的应用。
Cancer Cytopathol. 2018 May;126(5):342-352. doi: 10.1002/cncy.21987. Epub 2018 Mar 2.

引用本文的文献

1
Breast carcinoma with spontaneous regression after needle biopsy: a case report and literature review.针吸活检后自发消退的乳腺癌:一例报告及文献复习
Gland Surg. 2023 Jun 30;12(6):853-859. doi: 10.21037/gs-22-629. Epub 2023 Jun 13.
2
What Can Trigger Spontaneous Regression of Breast Cancer?什么会引发乳腺癌的自发消退?
Diagnostics (Basel). 2023 Mar 24;13(7):1224. doi: 10.3390/diagnostics13071224.
3
ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations.
乳腺癌间质肿瘤浸润淋巴细胞(sTILs)的ONEST(评估主观测试所需观察者)分析及其局限性
Cancers (Basel). 2023 Feb 14;15(4):1199. doi: 10.3390/cancers15041199.
4
Spontaneous regression of breast cancer with immune response: a case report.乳腺癌伴免疫反应的自发消退:一例报告
Surg Case Rep. 2021 Jan 6;7(1):10. doi: 10.1186/s40792-020-01103-5.
5
Temporary spontaneous regression of male breast cancer: a case report.男性乳腺癌的暂时性自发消退:一例报告
Surg Case Rep. 2020 Dec 7;6(1):311. doi: 10.1186/s40792-020-01088-1.
6
Crosstalk between Tumor Cells and Immune System Leads to Epithelial-Mesenchymal Transition Induction and Breast Cancer Progression.肿瘤细胞与免疫系统的串扰导致上皮-间充质转化诱导和乳腺癌进展。
Iran Biomed J. 2021 Jan;25(1):1-7. doi: 10.29252/ibj.25.1.1. Epub 2020 Jul 29.